Tonix Pharmaceuticals Holding Corp.
TNXP
$12.87
-$0.29-2.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 96.92% | 27.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 96.92% | 27.61% | |||
| Cost of Revenue | -55.45% | 49.15% | |||
| Gross Profit | 142.28% | 22.35% | |||
| SG&A Expenses | 25.63% | -19.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.83% | -9.80% | |||
| Operating Income | -2.40% | 13.98% | |||
| Income Before Tax | -0.89% | 14.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.89% | 14.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.89% | 14.32% | |||
| EBIT | -2.40% | 13.98% | |||
| EBITDA | -2.28% | 14.26% | |||
| EPS Basic | 16.87% | 26.25% | |||
| Normalized Basic EPS | 16.87% | 26.25% | |||
| EPS Diluted | 16.87% | 26.25% | |||
| Normalized Diluted EPS | 16.87% | 26.25% | |||
| Average Basic Shares Outstanding | 21.36% | 16.17% | |||
| Average Diluted Shares Outstanding | 21.36% | 16.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||